Edwards Lifesciences Corporation Stock
Stocks
EW
US28176E1082
Advanced Medical Equipment & Technology
|
Market Closed -
NYSE
04:00:03 2026-09-09 pm EDT
|
5-day change | 1st Jan Change | ||
| 86.18 USD | -0.62% |
|
-5.11% | +1.09% |
| Market Cap | 49.67B 42.74B 40.25B 36.67B 68.61B 4,727B 68.89B 477B 184B 2,408B 187B 182B 7,629B | P/E 2026 * |
34.1x | P/E 2027 * | 26.1x |
|---|---|---|---|---|---|
| Enterprise Value | 46.04B 39.62B 37.31B 33.99B 63.6B 4,381B 63.85B 442B 171B 2,232B 173B 169B 7,071B | EV / Sales 2026 * |
6.81x | EV / Sales 2027 * | 5.99x |
| Free-Float |
86.96% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| EW | Delayed | |
CBOE
| EW | Real-time | |
|
CBOE
| Real-time | ||
|
Mexican S.E.
| EW * | End-of-day quote | |
|
Tradegate
| EWL | Real-time | |
|
Boerse Muenchen
| EWL | Real-time | |
|
Xetra
| EWL | Delayed | |
|
Deutsche Boerse AG
| EWL | Delayed | |
|
Börse Stuttgart
| EWL | Delayed | |
|
Wiener Boerse
| EWLS | End-of-day quote | |
|
Borsa Italiana
| 1EW | End-of-day quote | |
|
Swiss Exchange
| EW | Delayed | |
|
Swiss Exchange
| EW | Delayed | |
|
CBOE
| 0REN | Real-time |
Last Transcript : Edwards Lifesciences Corporation
| 1 day | -0.62% | ||
| 1 week | -5.11% | ||
| Current month | -5.04% | ||
| 1 month | -3.95% | ||
| 3 months | -1.55% | ||
| 6 months | +2.28% | ||
| Current year | +1.09% |
| 1 week | 85.73 |  | 90.21 |
| 1 month | 85.73 | | 93.91 |
| Current year | 74.66 | | 96.29 |
| 1 year | 72.3 | | 96.29 |
| 3 years | 58.93 | | 96.29 |
| 5 years | 58.93 | | 131.73 |
| 10 years | 27.04 | | 131.73 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 58 | 2023-05-10 | |
Theodora Mistras
DFI | Director of Finance/CFO | 43 | 2026-05-28 |
| Chief Tech/Sci/R&D Officer | 51 | 2025-08-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 69 | 2024-05-06 | |
Kieran Gallahue
BRD | Director/Board Member | 62 | 2015-02-09 |
| Director/Board Member | 58 | 2023-05-10 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 8/31/26 | Sell | Controller/Auditor | -544 | 0.0001% | ||
| 8/28/26 | Sell | Executive/Senior Manager | -2,644 | 0.0005% | ||
| 8/26/26 | Sell | Executive/Senior Manager | -1,240 | 0.0002% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.62% | -5.11% | +7.99% | +16.35% | 49.67B | |
| +0.44% | -0.47% | +25.56% | +16.87% | 224B | |
| -0.19% | -2.41% | +5.41% | -17.52% | 144B | |
| +0.88% | -5.01% | -24.45% | +18.45% | 125B | |
| -0.04% | -7.05% | -58.41% | -16.54% | 65.16B | |
| -0.41% | -0.59% | -20.09% | -14.76% | 50.05B | |
| -1.43% | -4.39% | +14.65% | +26.98% | 40.81B | |
| +0.47% | -1.79% | +34.70% | +53.59% | 39.77B | |
| -2.87% | -3.87% | +108.72% | +29.45% | 30.96B | |
| -0.50% | -4.73% | -21.22% | +48.67% | 31.47B | |
| Average | -0.70% | -2.69% | +7.29% | +16.15% | 80.06B | |
| Weighted average by Cap. | -0.53% | -2.39% | +4.64% | +10.28% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 6.76B 5.82B 5.48B 4.99B 9.34B 643B 9.37B 64.91B 25.09B 328B 25.38B 24.83B 1,038B | 7.43B 6.39B 6.02B 5.48B 10.26B 707B 10.3B 71.34B 27.57B 360B 27.9B 27.29B 1,141B |
| Net income | 1.44B 1.23B 1.16B 1.06B 1.98B 137B 1.99B 13.78B 5.33B 69.57B 5.39B 5.27B 220B | 1.9B 1.63B 1.54B 1.4B 2.62B 180B 2.63B 18.21B 7.04B 91.95B 7.12B 6.97B 291B |
| Net Debt | -3.63B -3.12B -2.94B -2.68B -5.02B -345B -5.04B -34.87B -13.48B -176B -13.63B -13.34B -558B | -5.19B -4.47B -4.21B -3.84B -7.18B -494B -7.2B -49.88B -19.28B -252B -19.51B -19.08B -798B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-09 | $86.18 | -0.62% | 2,736,837 |
| 26-09-08 | $86.72 | -3.54% | 3,583,538 |
| 26-09-04 | $89.90 | +0.13% | 2,635,295 |
| 26-09-03 | $89.78 | -1.15% | 1,844,143 |
| 26-09-02 | $90.82 | +0.09% | 2,595,780 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- EW Stock
Select your edition
All financial news and data tailored to specific country editions
